Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion type Assertion NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_head.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion description "[These data suggest that the tumor-associated antigen MRP3 has potential use for prognosis and as a target for malignant glioma immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_provenance.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion evidence source_evidence_literature NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_provenance.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion SIO_000772 20809959 NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_provenance.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion wasDerivedFrom befree-20140225 NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_provenance.
- NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_assertion wasGeneratedBy ECO_0000203 NP482152.RANrNXQmOAcvE26aiwkkjVV8QqFGTjLox6qzPe9thQW_g130_provenance.